AccessibilityHelpAbout Us
Cronos Group logo

Cronos Group(TSX) CRON

Market CapCA$1.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+457%
5 Year-39%
1 Year+30%
1 Month+6%
CA$4.72
+2.17%
+0.10Today
Cronos Group last closing stock price
MetricPriceDate
Last closeCAD 4.622026-09-16
Cronos Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.45%CAD 4.342026-09-09
1 month+5.72%CAD 4.372026-08-17
3 month+20%CAD 3.852026-06-18
Year to date+28.33%CAD 3.602025-12-31
1 year+29.78%CAD 3.562025-09-16
3 year+42.15%CAD 3.252023-09-15
5 year-39.13%CAD 7.592021-09-17
Since inception+456.63%CAD 0.832014-12-18

Cronos Group Financials at a Glance

Market Cap

CA$1.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$179.03M

Net Income (TTM)

$69.73M

EPS (TTM)

CA$0.25

P/E Ratio

18.18

Dividend

CA$0.00

Beta (Volatility)

1.28 (Average)

Price

CA$4.72

Volume

109,781

Open

CA$4.68

Previous Close

CA$4.72

Daily Range

CA$4.65 - CA$4.77

52-Week Range

CA$3.23 - CA$4.99

Estimated Earnings Date

Nov 5, 2026

CRON News

marijuana leaf on green background

Marijuana Stocks: 7 Facts About Cronos Group's Quarterly Earnings

Todd CampbellMay 9, 2019
Happy businessman

Why Cronos Group Inc. Stock Rose Higher in August

George Budwell, PhDSep 3, 2018

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cronos Group

Cronos Group Inc. operates as a diversified global cannabinoid enterprise, focusing on the cultivation, production, and commercialization of cannabis products. The company offers a range of hemp-derived supplements and cannabis-infused products for both medicinal and adult-use sectors.

Products and Services
  • Hemp-derived supplements and cosmetics under Lord Jones and Happy Dance brands
  • Dried cannabis flower, pre-rolled joints, edibles, and extracts
  • International exports of cannabis and cannabis oils to markets like Germany and Australia
Growth Outlook
  • Recent quarterly revenue reached $53 million, indicating strong demand
  • Net income for Q2 was approximately $32 million, showcasing profitability
  • Cash and short-term investments total over $797 million, providing financial stability
Financial Highlights
  • Trailing twelve months (TTM) revenue of $197 million reflects consistent growth
  • Gross profit margin of 45.37% demonstrates effective cost management
  • Current ratio of 16.18 indicates strong liquidity position
Cronos Group Inc. has established itself as a key player in the cannabinoid industry, leveraging its diverse product offerings and strong financial position. The company's recent performance highlights its ability to generate significant revenue and maintain profitability, making it an attractive option for potential investors. With a robust cash position and a focus on expanding its market presence, Cronos Group is well-positioned for future growth in the evolving cannabis landscape.
AI Generated • Aug 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

610

CEO

Michael Ryan Gorenstein

Website

www.thecronosgroup.com

Headquarters

Stayner, ON L0M 1S0, CA

CRON Financials

Key Financial Metrics (TTM)

Gross Margin

45.37%

Operating Margin

0.30%

Net Income Margin

38.95%

Return on Equity

6.46%

Return on Capital

-1.63%

Return on Assets

5.91%

Earnings Yield

5.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$1.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

368.41M

Volume

109.78K

Avg. Volume

150.45K

Financials (TTM)

Gross Profit

$81.23M

Operating Income

$540.19K

EBITDA

$54.16M

Operating Cash Flow

$60.07M

Capital Expenditure

-$10.37M

Free Cash Flow

$49.70M

Cash & ST Invst.

$797.02M

Total Debt

$1.30M

Cronos Group Performance Analysis

Cronos Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 112,934,48821.0%
20232023-12-31USD 117,748,0414.3%
20242024-12-31USD 161,128,03236.8%
20252025-12-31USD 204,824,33927.1%
Cronos Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.6%
Q42025-12-3124.4%
Q12026-03-31-1.7%
Q22026-06-3019.2%
Cronos Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.58-56.6%
20232023-12-31USD -0.26-55.1%
20242024-12-31USD 0.15N/A
20252025-12-31USD -0.03N/A
Cronos Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30167.0%
Q42025-12-31-107.2%
Q12026-03-31837.5%
Q22026-06-30154.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$53.01M

+58.5%

Gross Profit

$28.45M

+96.2%

Gross Margin

53.67%

N/A

Market Cap

CA$1.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$2.79M

N/A

Employees

610

N/A

Net Income

$32.09M

+180.8%

EBITDA

$10.98M

+136.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$797.02M

-4.5%

Total Debt

$1.30M

-35.6%

Accounts Receivable

$57.04M

+44.9%

Inventory

$52.70M

+25.1%

Long Term Debt

$1.13M

-4.7%

Short Term Debt

$162.00K

-80.3%

Return on Assets

5.91%

N/A

Return on Invested Capital

0.05%

N/A

Free Cash Flow

$22.23M

+2279.2%

Operating Cash Flow

$24.01M

+752.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SIA.TOSienna Senior Living Inc.
CA$20.11+1.36%
WELL.TOWELL Health Technologies Corp.
CA$4.25+2.41%
GUD.TOKnight Therapeutics Inc.
CA$10.23+2.20%
TLRY.TOTilray Brands, Inc.
CA$5.51+0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$108.80+7.67%
NOKNokia
$10.60+4.54%
DAICCid HoldCo
$5.30+163.68%
NVDANvidia
$219.34+2.54%

Questions About CRON

What is the current price of Cronos Group?

Cronos Group is trading at CA$4.72 per share.

What is the 52-week range for Cronos Group?

Over the past 52 weeks, Cronos Group has traded between CA$3.23 and CA$4.99.

How much debt does Cronos Group have?

As of the most recent reporting period, Cronos Group reported total debt of $1.84M.

How much cash does Cronos Group have on hand?

Cronos Group reported $662.58M in cash and cash equivalents in its most recent financial results.

What is Cronos Group’s dividend yield?

Cronos Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services